Following up on general thoughts on antigenic drift of #COVID19 from this weekend, I wanted to discuss what we know about the new variant of SARS-CoV-2 thats emerged in the UK. 1/17https://twitter.com/trvrb/status/1340409968818671616 …
-
-
Agreed. Major implications for the funding, procurement priorities & allocation mechanisms for the COVAX Facility, as well as further research & manufacturing investments by CEPI .
-
Moreover, the likely need for regular formulation updates will be an additional unexpected hurdle for licensing agreements & tech transfer to local manufacturers, not to mention national regulatory capacity.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
coverage. (Which means I have my charge!)